Texas A&M Football

Lunch with Liucci: Billy Liucci joins TexAgs Radio (Monday, October 2)

TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Monday morning to share his thoughts following Texas A&M's beatdown of Arkansas at AT&T Stadium. Now 2-0 in SEC play, Liucci discussed what will be a giant showdown at Kyle Field vs. Alabama.
By Billy Liucci
October 2, 2023
6.9k Views
Discuss
Story Poster

TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Monday morning to share his thoughts following Texas A&M's beatdown of Arkansas at AT&T Stadium. Now 2-0 in SEC play, Liucci discussed what will be a giant showdown at Kyle Field vs. Alabama.


Segment 1 (00:00:00 - 14:22:24)

  • I don't know that “clean” is the best word. The pick-six was on Max Johnson. Those fumbles, he has to clean up. You have to be selective when you run.
To view this content, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Bobby Petrino TexAgs Live TexAgs Live Feature Gene Stallings Nick Saban Lane Kiffin Johnny Manziel Jimbo Fisher Lunch with Liucci Jayden Daniels Spencer Rattler Will Rogers
Show All
KJ Jefferson Bear Bryant Texas A&M vs. Arkansas Texas A&M vs. Alabama Demani Richardson Ainias Smith Max Johnson Zach Calzada Kam Dewberry Reuben Fatheree II Dametrious Crownover Trey Zuhn III Le'Veon Moss Chase Bisontis Football Texas A&M Arkansas Missouri LSU Georgia South Carolina Mississippi State Miami Alabama Ole Miss Kentucky 2023
SPONSORED BY
12th Man Foundation
More Football
See All →
Young wideout Madden Williams is adapting to life at Texas A&M
By David Nuño
TexAgs Rewind (2/10)
By TexAgs Live
Will Johnson joins TexAgs Live to talk A&M football, basketball & baseball
By David Nuño
ProFootballTalk.com's Charean Williams recaps Super Bowl experience
By David Nuño
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.